Literature DB >> 10891443

The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1.

G J Zaman1, E M Conway.   

Abstract

The coagulation protease factor Xa induces cellular responses implicated in cardiovascular and inflammatory disease. Effector-cell protease receptor 1 (EPR-1) is a functionally characterized receptor of factor Xa, and the EPR-1 complementary DNA (cDNA) was published. Remarkably, the cDNA encoding an inhibitor of apoptosis, survivin, is reportedly identical to that of EPR-1 except for a few nucleotide differences and its orientation opposite to EPR-1. To isolate the EPR-1 cDNA and gene, we surveyed gene databases for expressed sequence tags (ESTs) that could be derived from EPR-1. All ESTs with strong homology to EPR-1/survivin were derived from survivin and could not encode EPR-1. By polymerase chain reaction and Southern blot hybridization, EPR-1 was not detectable in the human or murine genome, but survivin was. Our data suggest that EPR-1 is either highly cell-specific or the published EPR-1 cDNA includes sequences from clones derived from survivin messenger RNA. The means by which factor Xa mediates its cellular effects requires further evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891443

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Survivin promoter -31G/C polymorphism in oral cancer cell lines.

Authors:  Salvatore de Maria; Lorenzo Lo Muzio; Alessandra Braca; Paolo Rega; Amalia Cassano; Angela Vinella; Ruggiero Fumarulo; Rosario Serpico; Ernesto Farina; Vittoria Metafora; Giuseppe Pannone; Gian Pietro Ravagnan; Salvatore Metafora; Corrado Rubini; Maria Carteni; Maria Addolorata Mariggiò
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

2.  Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1.

Authors:  Jong-Sup Bae; Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

3.  Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.

Authors:  Eimear M Gleeson; James S O'Donnell; Emily Hams; Fionnuala Ní Áinle; Bridget-Ann Kenny; Padraic G Fallon; Roger J S Preston
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

4.  Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome.

Authors:  Mandy Glass; Ariane Söling; Martin Messerle
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

5.  Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.

Authors:  A Krieg; C Mahotka; T Krieg; H Grabsch; W Müller; S Takeno; C V Suschek; M Heydthausen; H E Gabbert; C D Gerharz
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

6.  Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel.

Authors:  Eliza Li Shan Fong; Tan Boon Toh; Quy Xiao Xuan Lin; Zheng Liu; Lissa Hooi; Masturah Bte Mohd Abdul Rashid; Touati Benoukraf; Edward Kai-Hua Chow; The Hung Huynh; Hanry Yu
Journal:  Data Brief       Date:  2018-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.